Metabolic Effects of Oral Versus Transdermal 17β-Estradiol (E2): A Randomized Clinical Trial in Girls With Turner Syndrome | Zendy

Lournaris TorresSantiago | Zendy; Verónica Mericq | Zendy; Martha Taboada | Zendy; Nancy Unanue | Zendy; Karen Oerter Klein | Zendy; Ravinder J. Singh | Zendy; Jobayer Hossain | Zendy; Richard J. Santen | Zendy; Judith L. Ross | Zendy; Nelly Mauras | Zendy

Open Access

Metabolic Effects of Oral Versus Transdermal 17β-Estradiol (E2): A Randomized Clinical Trial in Girls With Turner Syndrome

Author(s) -

Lournaris TorresSantiago,

Verónica Mericq,

Martha Taboada,

Nancy Unanue,

Karen Oerter Klein,

Ravinder J. Singh,

Jobayer Hossain,

Richard J. Santen,

Judith L. Ross,

Nelly Mauras

Publication year - 2013

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2012-4243

Subject(s) - endocrinology , medicine , transdermal , chemistry , estrogen , osteocalcin , lipid oxidation , lipid profile , bone mineral , oral administration , cholesterol , pharmacology , alkaline phosphatase , osteoporosis , biochemistry , antioxidant , enzyme

The long-term effects of pure 17β-estradiol (E₂) depending on route of administration have not been well characterized.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research